Abstract:Dysfunctional mitochondrial metabolism and sustained de novo lipogenesis are characteristic of non-alcoholic fatty liver disease (NAFLD), a common comorbidity of obesity and type 2 diabetes. We hypothesize that sustained de novo lipogenesis, through its biochemical relationships with mitochondria (e.g., tri-carboxylic acid (TCA) cycle) can contribute to dysfunctional oxidative flux during NAFLD. In study 1, male mice (C57BL/6JN) were fed either a low-fat (LF; 10% fat Kcal), high-fat (HF; 60% fat Kcal), or high-fructose/HF diet (HFr/HF; 34.9% fructose Kcal, 25% fat Kcal) for 24-wks. Liver mitochondria were utilized to determine oxygen consumption and were incubated in a buffer (for 5-min) to determine changes in TCA cycle intermediates, using gas chromatography-mass spectrometry (GC-MS). Plasma and liver samples were utilized for GC-MS based metabolomics and determination of gene and protein expression. In study 2, C57BL/6JN mice were provided 30% fructose in drinking water (FW) for 2-wks to induce hepatic de novo lipogenesis vs. mice given regular water (RW). Liver mitochondria were incubated in a buffer containing 1mM [ 13 C 3 ]pyruvate or 2.5mM [ 13 C 4 ]malate for 5-min. Isotopomer distribution of the TCA cycle intermediates were determined using GC-MS. Both HF and HFr/HF diets resulted in similar degrees of hepatic steatosis. However, lipogenic gene expression ( Scd1, Acyl, Fasn) and fasting plasma β-hydroxybutyrate levels were higher (p<0.001) in HFr/HF vs. HF group. Further, the feeding-to-fasting induction of genes involved in lipid oxidation ( Cpt1α, Lcad, Hmgcs2) was higher (p ≤0.01) in HFr/HF vs. HF livers. After 5-min of incubation, the HFr/HF liver mitochondria had higher (p<0.05) TCA cycle intermediates vs. the HF. The HFr/HF mitochondria also had higher expression of oxidative phosphorylation proteins and higher oxygen consumption rates (OCR), vs. the HF (p<0.05). In study 2, fructose in drinking water induced hepatic de novo lipogenesis. Induction of lipogenesis was also accompanied by higher mitochondrial OCR, higher reactive oxygen species, and higher TCA cycle metabolism (p<0.05). Gene expression of components of the mitochondrial nutrient shuttles ( SLC25A13, MPC1, MPC2, ME1) was upregulated in lipogenic livers (p<0.05). Incorporation of 13 C from [ 13 C 4 ]malate into pyruvate and α-ketoglutarate, indices of malic enzyme and TCA cycle activity, were higher (p<0.05) in lipogenic livers. Similarly, incorporation of 13 C from [ 13 C 3 ]pyruvate into aspartate and citrate, indices of pyruvate carboxylase and pyruvate dehydrogenase activity, were also higher (p<0.05) in lipogenic livers. These results demonstrate that the induction of several facets of mitochondrial oxidative metabolism and de novo lipogenesis accompany a carbohydrate-rich dietary milieu and NAFLD. Sustained induction of both de novo lipogenesis and mitochondrial oxidative function could contribute to the progression of metabolic dysfunction during NAFLD. National Institutes of Health R01 DK112865 This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

1334-P: Hepatocyte D-ß-Hydroxybutyrate Dehydrogenase Deficiency Improves Glucose Homeostasis and Prevents Diet-Induced Liver Fibrosis

Diminished ketone interconversion, hepatic TCA cycle flux, and glucose production in D-β-hydroxybutyrate dehydrogenase hepatocyte-deficient mice

1567-P: Hepatic ALKBH5 Regulation of Glucose and Lipid Metabolism

SAT112 Ad Libitum Ketogenic Diet Reverts WD-pathological Effects In Liver, But Not In Skeletal Muscle In Mice

120-LB: Small Molecule Activator of Pyruvate Kinase Regulates In Vivo Glucose Homeostasis

Ketone-loading as A Novel Sports Nutrition Strategy: Chronic Ketone Supplementation Elicits Further Favorable Metabolic Changes in Keto-adapted Mice

224-OR: Antisense Oligonucleotide–Mediated Restriction of Mitochondrial Pyruvate Metabolism Limits DNL in High-Fat Fed C57BL6/J Mice

Impact of sustained de novo lipogenesis on mitochondrial dysfunction and hepatocellular redox during fatty liver disease

Hepatic Insulin Resistance is Not Pathway Selective in Humans with Nonalcoholic Fatty Liver Disease

BDH1-mediated βOHB metabolism ameliorates diabetic kidney disease by activation of NRF2-mediated antioxidative pathway

Ketogenic diet alleviates β-cell dedifferentiation but aggravates hepatic lipid accumulation in db/db mice

BDK inhibition acts as a catabolic switch to mimic fasting and improve metabolism in mice

Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice

ACBP/DBI neutralization for the experimental treatment of fatty liver disease

1,3-Butanediol Administration Increases β-Hydroxybutyrate Plasma Levels and Affects Redox Homeostasis, Endoplasmic Reticulum Stress, and Adipokine Production in Rat Gonadal Adipose Tissue

283-LB: Dissociating Insulin Signaling and SREBP1c Action from the Lipogenic Drive Seen in Human and Murine Hepatic Insulin Resistance

Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver

Resistance to High-fat Diet-Induced Obesity and Insulin Resistance in Mice with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency

Hepatocyte-derived DPP4 regulates portal GLP-1 bioactivity, modulates glucose production, and when absent influences NAFLD progression

D-β-Hydroxybutyrate Dehydrogenase Mitigates Diabetes-Induced Atherosclerosis through the Activation of Nrf2

Ketone ester administration improves glycemia in obese mice